In:
eLife, eLife Sciences Publications, Ltd, Vol. 3 ( 2014-12-23)
Abstract:
Neurofibromatosis type 1 is a condition characterized by the growth of tumors along the nerves of the body. It is caused by mutations in a gene called NF1, which codes for a protein that normally works to inhibit the activity of another protein called Ras. In healthy cells, Ras is needed to stimulate the cells to grow and divide. However, if the Ras protein is not turned off at the right time or if it is activated at the wrong time, it can force cells to keep growing and dividing; this leads to the growth of tumors. Along with being prone to developing cancer, individuals with neurofibromatosis type 1 also develop a range of neurodevelopmental disorders that alter their learning, motor skills and social interactions. Some also exhibit behaviors that are associated with autism. This led Kim, Wang et al. to investigate whether a region of the brain—called the cerebellum—that has recently been associated with autism is also affected in a mouse model of neurofibromatosis type 1. The cerebellum is best known for its role in coordinating movement, although it also has functions in cognition, behavior and other processes. Ras is involved in the development of the cerebellum; and so Kim, Wang et al. asked whether the loss of the Nf1 gene from cells in the mouse cerebellum might cause the neurodevelopmental defects associated with neurofibromatosis type 1. Loss of Nf1 during early (but not in late) development of the cerebellum disrupted the normal organization of the nerve cells (or neurons) into specific cell layers. These defects were caused, in part, by the over-growth of a type of supporting cell—called glia cells—at a specific developmental stage—that would normally form a scaffold to help neurons migrate to their correct position. Nf1 also controls the generation of the correct types of neurons in the right time and at right location during the early development of the cerebellum. Next, Kim, Wang et al. treated newborn mice with a compound that inhibits Ras signaling via their mother's milk for 3 weeks. In mice with an inactive Nf1 gene, the treatment helped to prevent some defects in the cerebellum and the mice had improved motor coordination several months later. Whether this could form the basis of a preventative treatment for neurodevelopmental disorders associated with neurofibromatosis type 1 in humans remains a question for future work.
Type of Medium:
Online Resource
ISSN:
2050-084X
DOI:
10.7554/eLife.05151.001
DOI:
10.7554/eLife.05151.002
DOI:
10.7554/eLife.05151.003
DOI:
10.7554/eLife.05151.004
DOI:
10.7554/eLife.05151.005
DOI:
10.7554/eLife.05151.006
DOI:
10.7554/eLife.05151.007
DOI:
10.7554/eLife.05151.008
DOI:
10.7554/eLife.05151.009
DOI:
10.7554/eLife.05151.010
DOI:
10.7554/eLife.05151.011
DOI:
10.7554/eLife.05151.012
DOI:
10.7554/eLife.05151.013
DOI:
10.7554/eLife.05151.014
DOI:
10.7554/eLife.05151.015
DOI:
10.7554/eLife.05151.016
DOI:
10.7554/eLife.05151.017
DOI:
10.7554/eLife.05151.018
DOI:
10.7554/eLife.05151.019
DOI:
10.7554/eLife.05151.020
DOI:
10.7554/eLife.05151.021
DOI:
10.7554/eLife.05151.022
DOI:
10.7554/eLife.05151.023
Language:
English
Publisher:
eLife Sciences Publications, Ltd
Publication Date:
2014
detail.hit.zdb_id:
2687154-3
Permalink